Wellcome Trust reposted this
🌍 A landmark moment for African vaccine manufacturing and regional health security. I’m delighted to see our partners at Biovac, with the South African Medical Research Council (SAMRC), announce they are beginning clinical trials for an Oral Cholera Vaccine (OCV). This is the first time in over 50 years that a preventative vaccine is being manufactured end-to-end in South Africa. I remember some of my first conversations about the potential of Biovac back in 2017! So it’s fantastic to see that, after so many years in the ‘thinking’, we’re now firmly ‘advancing’. This work is critical. #Cholera outbreaks are growing, yet we face repeated, severe shortages of OCV doses 💉 The global vaccine stockpile simply cannot meet the demand, leaving millions exposed to a preventable and deadly disease. This work has far-reaching impacts. It is about building a sustainable, regional manufacturing capability that can respond directly to the continent's health needs. It’s a crucial step towards the African Union's goal of 60% of all routine vaccines used in Africa to be manufactured on the continent by 2030, and a future where local solutions can save lives. This is why Wellcome Trust is proud to be a long-term partner in this work. We co-funded the initial technology transfer between International Vaccine Institute (IVI) in South Korea and Biovac, with the Gates Foundation and are now co-funding this crucial clinical trial alongside them and the ELMA Vaccines & Immunization Foundation. 🎉 Congratulations to the Biovac team and all partners on this historic milestone. Read the full announcement 👉 https://lnkd.in/esaiFzvq